Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001683168-24-007019
Filing Date
2024-10-09
Accepted
2024-10-09 15:16:47
Documents
15
Period of Report
2024-03-08
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A bioregenx_8ka.htm   iXBRL 8-K/A 34458
2 AUDITED HISTORICAL FINANCIAL STATEMENTS OF BIOREGENX, INC. AS OF AND FOR THE YEA bioregenx_ex9903.htm EX-99.3 291243
3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION FOR THE COMPANY AS bioregenx_ex9904.htm EX-99.4 55867
  Complete submission text file 0001683168-24-007019.txt   603202

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE fdit-20240308.xsd EX-101.SCH 3009
5 XBRL LABEL FILE fdit-20240308_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE fdit-20240308_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT bioregenx_8ka_htm.xml XML 3746
Mailing Address 7407 ZIEGLER ROAD CHATTANOOGA TN 37421
Business Address 7407 ZIEGLER ROAD CHATTANOOGA TN 37421 (866) 770-4067
BIOREGENX, INC. (Filer) CIK: 0001593184 (see all company filings)

EIN.: 462836541 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-56345 | Film No.: 241362609
SIC: 7370 Services-Computer Programming, Data Processing, Etc.
(CF Office: 06 Technology)